ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.
Von Eschenbach says oncology is undergoing a “revolutionary evolution.”
CCOPs ask NCI officials about one-year extensions.
Varmus: Why are scientific societies obstructing public access to research results?
Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says.
Onward to 2010? NCI promises faster progress for more money.
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings
